Producing nitric oxide by pulsed electrical discharge in air for portable inhalation therapy

Generating nitric oxide from air by pulsed electrical discharge produces therapeutic levels of nitric oxide for inhalation and provides effective pulmonary vasodilation. Breath of fresh NO Inhalation therapy—an expensive, yet life-saving, treatment for pulmonary hypertension—is not common in many parts of the world or in patients’ homes. To make inhaled nitric oxide (NO) available to all, at the bedside, Yu et al. designed a lightweight, portable system that created NO from ambient air or oxygen-nitrogen mixtures. Their generator used a pulsed electrical spark from an iridium electrode to create gaseous NO, pump it through a scavenger (to remove toxic gases like ozone), and then deliver it constantly or only during inspiration. The device was designed to have all components, including the scavenger, inline, making it self-contained and portable. The NO produced was equivalent to NO delivered from a cylinder, the current clinical gold standard, when treating lambs with pulmonary hypertension. It is hoped that this new economical technology for NO inhalation therapy will liberate patients from costly, cumbersome tanks and complicated delivery and monitoring systems, in emergency situations and in their own homes. Inhalation of nitric oxide (NO) produces selective pulmonary vasodilation and is an effective therapy for treating pulmonary hypertension in adults and children. In the United States, the average cost of 5 days of inhaled NO for persistent pulmonary hypertension of the newborn is about $14,000. NO therapy involves gas cylinders and distribution, a complex delivery device, gas monitoring and calibration equipment, and a trained respiratory therapy staff. The objective of this study was to develop a lightweight, portable device to serve as a simple and economical method of producing pure NO from air for bedside or portable use. Two NO generators were designed and tested: an offline NO generator and an inline NO generator placed directly within the inspiratory line. Both generators use pulsed electrical discharges to produce therapeutic range NO (5 to 80 parts per million) at gas flow rates of 0.5 to 5 liters/min. NO was produced from air, as well as gas mixtures containing up to 90% O2 and 10% N2. Potentially toxic gases produced in the plasma, including nitrogen dioxide (NO2) and ozone (O3), were removed using a calcium hydroxide scavenger. An iridium spark electrode produced the lowest ratio of NO2/NO. In lambs with acute pulmonary hypertension, breathing electrically generated NO produced pulmonary vasodilation and reduced pulmonary arterial pressure and pulmonary vascular resistance index. In conclusion, electrical plasma NO generation produces therapeutic levels of NO from air. After scavenging to remove NO2 and O3 and filtration to remove particles, electrically produced NO can provide safe and effective treatment of pulmonary hypertension.

[1]  K. Barrington,et al.  Nitric oxide for respiratory failure in infants born at or near term. , 2017, The Cochrane database of systematic reviews.

[2]  L. Gamero,et al.  Generation of purified nitric oxide from liquid N2O4 for the treatment of pulmonary hypertension in hypoxemic swine. , 2014, Nitric oxide : biology and chemistry.

[3]  B. Goldstein,et al.  Pulmonary Circulation | April-june 2012 | Vol 2 | No 2 Review Ar Ticle Clinical Perspectives with Long-term Pulsed Inhaled Nitric Oxide for the Treatment of Pulmonary Arterial Hypertension , 2022 .

[4]  J. Barberà,et al.  Effects of inhaled nitric oxide at rest and during exercise in idiopathic pulmonary fibrosis. , 2011, Journal of applied physiology.

[5]  R. Gesche,et al.  Non-thermal atmospheric pressure HF plasma source: generation of nitric oxide and ozone for bio-medical applications , 2010 .

[6]  S. Katsuki,et al.  Nitric oxide generated by atmospheric pressure air microplasma , 2009, 2009 IEEE Pulsed Power Conference.

[7]  S. Herndon,et al.  A practical alternative to chemiluminescence-based detection of nitrogen dioxide: cavity attenuated phase shift spectroscopy. , 2008, Environmental science & technology.

[8]  C. Dewhurst,et al.  Is nitric oxide effective in preterm infants? , 2007, Archives of Disease in Childhood Fetal and Neonatal Edition.

[9]  Junjia He,et al.  Study on Production of Inhaled Nitric Oxide for Medical Applications by Pulsed Discharge , 2007, IEEE Transactions on Plasma Science.

[10]  K. Barrington,et al.  Cochrane review: Nitric oxide for respiratory failure in infants born at or near term , 2007 .

[11]  N. Yavorovsky,et al.  Generation of Active Oxidant Species by Pulsed Dielectric Barrier Discharge in Water-Air Mixtures , 2006 .

[12]  Eva Stoffels,et al.  A plasma needle generates nitric oxide , 2006 .

[13]  W. Zapol,et al.  Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. , 2005, Chest.

[14]  P. Germann,et al.  Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD , 2003, Thorax.

[15]  Ahmed Addou,et al.  Density and Rotational Temperature Measurements of the OH° and NO° Radicals Produced by a Gliding Arc in Humid Air , 2002 .

[16]  R. Hackam,et al.  Production of nitric oxide using a pulsed arc discharge , 2002 .

[17]  M. Oz,et al.  Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. , 2002, The Annals of thoracic surgery.

[18]  A. Napartovich,et al.  Kinetics of ozone and nitric oxides in dielectric barrier discharges in O2/NOx and N2/O2/NOx mixtures , 2001 .

[19]  R. Hackam,et al.  Production of nitric monoxide using pulsed discharges for a medical application , 2000 .

[20]  Serio,et al.  Control of nitric oxide, nitrous oxide, and ammonia emissions using microwave plasmas , 2000, Journal of hazardous materials.

[21]  M. Keszler,et al.  Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. , 2000, The New England journal of medicine.

[22]  R. Hackam,et al.  Production of nitric monoxide in dry air using pulsed discharge , 1999, Digest of Technical Papers. 12th IEEE International Pulsed Power Conference. (Cat. No.99CH36358).

[23]  R. Hackam,et al.  Ozone production by pulsed power in dry air , 1999, Digest of Technical Papers. 12th IEEE International Pulsed Power Conference. (Cat. No.99CH36358).

[24]  C. Mayoux,et al.  Experimental and theoretical study of a glow discharge at atmospheric pressure controlled by dielectric barrier , 1998 .

[25]  A. Atz,et al.  Inhaled nitric oxide in the neonate with cardiac disease. , 1997, Seminars in perinatology.

[26]  A. Denjean,et al.  Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. , 1995, American journal of respiratory and critical care medicine.

[27]  R. Kacmarek,et al.  Hemodynamic effects of inhaled nitric oxide in heart failure. , 1994, Journal of the American College of Cardiology.

[28]  E. Shaffer,et al.  Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.

[29]  Jesse D. Roberts,et al.  Inhaled nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.

[30]  J. Wain,et al.  Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator Reversing Hypoxic Pulmonary Vasoconstriction , 1991, Circulation.

[31]  R. Rinker,et al.  Experimental study of the production of nitric oxide, nitrous oxide, and ozone in a simulated atmospheric corona , 1988 .

[32]  H. Akiyama,et al.  Kumamoto University Repository System Title A Compact Nitric Oxide Supply for Medical Application , 2018 .

[33]  S. Abman Inhaled nitric oxide for the treatment of pulmonary arterial hypertension. , 2013, Handbook of experimental pharmacology.

[34]  E. I. Archibong,et al.  A continuing problem , 2003 .